Birth control pill most popular form of contraception in U.S.
Results from in-person interviews of women found that during 2006-2008 the most popular form of contraception in the U.S. was the oral contraception pill,…
Women’s Health
Intraperitoneal chemotherapy: Improving the odds for ovarian cancer patients
Patients with ovarian cancer may receive intraperitoneal (IP) chemotherapy, which delivers chemotherapeutic agents directly into the peritoneal cavity. Drugs given by this route include…
March of Dimes releases new nursing education modules
The March of Dimes has released three new nursing education modules: Diabetes in Pregnancy, 4th Edition; Genetic Issues for Perinatal Nurses, 3rd Edition; and…
Drug approval for breast cancer
The U.S. Food and Drug Administration has approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced breast cancer…
HAART and its effects on the heart
Many patients with HIV/AIDS are doing well on highly active antiretroviral therapy (HAART). Yet HAART can increase cardiovascular risks by reducing high-density lipoprotein levels,…
Drugs Today – July/August 2009
A weekly update of drug news, including alerts, approvals, and removals.
Osteoporosis-not just for women
Most elderly men don’t know they are at risk for osteoporosis-and they probably won’t find out until a nurse tells them.
Neonatal nurses: Providing care at the beginning of life
About 400,000 low-birth-weight infants are born in this country every year. Their survival rates have been improving steadily, thanks to great strides in neonatal…
Drugs Today – October 2008
Web Exclusive! An update of drug news, including alerts, approvals, and removals.
Birth control pill most popular form of contraception in U.S.
Results from in-person interviews of women found that during 2006-2008 the most popular form of contraception in the U.S. was the oral…
Intraperitoneal chemotherapy: Improving the odds for ovarian cancer patients
Patients with ovarian cancer may receive intraperitoneal (IP) chemotherapy, which delivers chemotherapeutic agents directly into the peritoneal cavity. Drugs given by this…
March of Dimes releases new nursing education modules
The March of Dimes has released three new nursing education modules: Diabetes in Pregnancy, 4th Edition; Genetic Issues for Perinatal Nurses, 3rd…
Drug approval for breast cancer
The U.S. Food and Drug Administration has approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced…
HAART and its effects on the heart
Many patients with HIV/AIDS are doing well on highly active antiretroviral therapy (HAART). Yet HAART can increase cardiovascular risks by reducing high-density…
Drugs Today – July/August 2009
A weekly update of drug news, including alerts, approvals, and removals.
Osteoporosis-not just for women
Most elderly men don’t know they are at risk for osteoporosis-and they probably won’t find out until a nurse tells them.
Neonatal nurses: Providing care at the beginning of life
About 400,000 low-birth-weight infants are born in this country every year. Their survival rates have been improving steadily, thanks to great strides…
Drugs Today – October 2008
Web Exclusive! An update of drug news, including alerts, approvals, and removals.
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.